(Q48160360)

9 February 2018

title

Brain natriuretic peptide is elevated in outpatients with atrial fibrillation (English)

1 reference

https://api.crossref.org/works/10.1016/J.AMJCARD.2003.07.010

Cardiology and cardiovascular medicine

26 March 2024

main subject

atrial fibrillation

0 references

1 reference

https://api.crossref.org/works/10.1016/J.AMJCARD.2003.07.010

26 March 2024

author name string

Helme Silvet

1

1 reference

9 February 2018

Yinong Young-Xu

2

1 reference

9 February 2018

Diana Walleigh

3

1 reference

9 February 2018

Shmuel Ravid

4

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 November 2003

1 reference

9 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0002914903010531?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.AMJCARD.2003.07.010

https://api.elsevier.com/content/article/PII:S0002914903010531?httpAccept=text/plain

26 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.AMJCARD.2003.07.010

American Journal of Cardiology

26 March 2024

published in

1 reference

9 February 2018

volume

92

1 reference

9 February 2018

page(s)

1124-1127

1 reference

9 February 2018

issue

9

1 reference

9 February 2018

New insights into the cardiac natriuretic peptides

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.AMJCARD.2003.07.010

Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction.

26 March 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.AMJCARD.2003.07.010

Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina

26 March 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.AMJCARD.2003.07.010

Increased human brain natriuretic peptide in congestive heart failure.

26 March 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.AMJCARD.2003.07.010

B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next?

26 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.AMJCARD.2003.07.010

Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.

26 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.AMJCARD.2003.07.010

Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide

26 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.AMJCARD.2003.07.010

Effect of the maze procedure for atrial fibrillation on atrial and brain natriuretic peptide.

26 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.AMJCARD.2003.07.010

Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study

26 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.AMJCARD.2003.07.010

Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method

26 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.AMJCARD.2003.07.010

Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction.

26 March 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.AMJCARD.2003.07.010

Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: evidence from a population-based study.

26 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.AMJCARD.2003.07.010

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study

26 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.AMJCARD.2003.07.010

26 March 2024

Identifiers

1 reference

9 February 2018

PubMed ID

14583372

1 reference

9 February 2018